Home » Topics » Briefs » Other news to note

Other news to note
RSS

Receptagen demerger on the table at AGM

May 17, 1996

Hafslund Nycomed demerger approved at AGM

May 17, 1996

Allergan calls off merger discussions with Pharmacia & Upjohn

May 17, 1996

SmithKline Beecham's C-DART approach to rheumatoid arthritis

May 17, 1996

Progene Partners dissolved upon completion of goals

May 10, 1996

OncoRx gets new identity: Vion Pharmaceuticals

May 3, 1996

Sandoz to acquire Imutran

May 3, 1996

Bristol-Myers Squibb opens R&D office in Russia

May 3, 1996

Hafslund Nycomed demerger imminent

May 3, 1996

BMS-193884 in development for heart failure

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 1, 2025.
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Otsuka submits first BLA to FDA for sibeprenlimab in IgAN
BioWorld
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The...